Global Prefilled Syringes Market Analysis

The global prefilled syringes market is projected to grow from USD 9.15 billion in 2025 to USD 18.73 billion by 2032, exhibiting a CAGR of 10.8%.
Market Overview
Europe dominates the market with a 40.61% share in 2024. The region's leadership stems from increasing adoption of biologics and advanced delivery methods for self-injection of drugs.
Key Growth Drivers
• Rising burden of chronic conditions like cancer and diabetes
• Growing emphasis on safety from needlestick injuries
• Increasing demand for biologics and biosimilars
• Focus on technological advancements in product development
According to the International Agency for Research on Cancer (IARC), global cancer burden is expected to reach 27.5 million new cases by 2040.
Market Segments
By Material
• Glass: Dominates due to prevention of drug compound interaction with water vapor & oxygen
• Plastic: Growing due to technological innovations offering advantages over glass
By Closing System
• Staked needle system: Largest share due to simplified steps and fewer errors
• Luer cone system
• Luer lock form system
By Design
• Single-chamber: Largest share due to technological innovations
• Double-chamber: Growing demand for lyophilized drugs
• Multiple-chamber
Key Market Players
Leading companies include:
• BD (U.S.)
• SCHOTT Pharma (Germany)
• Gerresheimer AG (Germany)
• West Pharmaceutical Services, Inc. (U.S.)
Recent Developments
• January 2025: SCHOTT Pharma launched SCHOTT TOPPAC infuse polymer syringes
• December 2024: Gerresheimer AG expanded production capacity in Skopje, North Macedonia
• September 2024: BD announced capacity expansion of Neopak Glass Prefillable Syringe platform
Regional Analysis
Europe
• Market value: USD 3.44 billion (2024)
• Strong adoption of advanced delivery methods
• Favorable reimbursement models in Germany
North America
• Second-largest market share
• U.S. dominated with USD 3.03 billion revenue in 2024
• Growth driven by improved healthcare infrastructure
Asia Pacific
• Fastest growing region
• Driven by:
o Rising chronic disease prevalence
o Healthcare infrastructure improvements
o Growing contract manufacturing sector